Skip to main content

Table 1 The baseline demographic and clinical characteristics of the study group

From: Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease

Descriptive parameter Range Mean ± S.D
Age 16-85 years 48.26 ± 17.91
Disease duration 1-20 years 7.29 ± 3.93
ESR 8-119 mm/hr 51.00 ± 25.30
CRP 6-136.50 mg/l 35.18 ± 31.65
Hemoglobin 10-16gm/dl 11.56 ± 1.30
Rheumatoid factor 0-849 141.09 ± 157.88
Anti-CCP 0-450 230.05 ± 156.35
DAS 3-7.5 6.0 ± 1.0
HAQ 0.5-8 1.30 ± 0.71
VAS 5-10 6.70 ± 0.95
Medications: Number of patients Percentage%
Conventional DMARDs 58 72.5
Methotrexate 64 80
Oral corticosteroids 53 66.2
Non-steroidal drugs 80 100
  1. Abbreviations: ESR: erythrocyte sedimentation rate, CRP: C- reactive protein, Anti-CCP: anti-citrullinated C peptide, DAS-28: disease activity score, HAQ: health assessment questionnaire, VAS: visual analogue scale for pain.